| Q24624026 | Acetaminophen-associated hepatic injury: evaluation of acetaminophen protein adducts in children and adolescents with acetaminophen overdose |
| Q33845461 | Acetaminophen-cysteine adducts during therapeutic dosing and following overdose |
| Q34715731 | Acetaminophen-induced hepatotoxicity in mice occurs with inhibition of activity and nitration of mitochondrial manganese superoxide dismutase |
| Q40494497 | Adenovirus mediated overexpression of CYP2E1 increases sensitivity of HepG2 cells to acetaminophen induced cytotoxicity |
| Q35788415 | Echinomycin decreases induction of vascular endothelial growth factor and hepatocyte regeneration in acetaminophen toxicity in mice |
| Q35830716 | Immunohistochemical localization and quantification of the 3-(cystein-S-yl)-acetaminophen protein adduct in acetaminophen hepatotoxicity |
| Q34013719 | Lactoferrin protects against acetaminophen-induced liver injury in mice |
| Q24629891 | Mechanisms of acetaminophen-induced liver necrosis |
| Q38212434 | Mechanistic biomarkers in acetaminophen-induced hepatotoxicity and acute liver failure: from preclinical models to patients |
| Q37266295 | Pharmacokinetics of acetaminophen-protein adducts in adults with acetaminophen overdose and acute liver failure |
| Q55192083 | Simple reversed-phase HPLC method with spectrophotometric detection for measuring acetaminophen-protein adducts in rat liver samples. |
| Q27653174 | Structural and Kinetic Analyses of Macrophage Migration Inhibitory Factor Active Site Interactions † ‡ |
| Q35080126 | Susceptibility to acetaminophen (APAP) toxicity unexpectedly is decreased during acute viral hepatitis in mice |
| Q36072453 | Target biomarker profile for the clinical management of paracetamol overdose |
| Q35572609 | The proper use of acetaminophen |
| Q36001451 | Translational biomarkers of acetaminophen-induced acute liver injury |
| Q35529749 | Unrecognized acetaminophen toxicity as a cause of indeterminate acute liver failure |